Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and linagliptin

fluorodeoxyglucose f18 has been researched along with linagliptin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
de Boer, SA; Glaudemans, AW; Heerspink, HJ; Hovinga-de Boer, MC; Juárez Orozco, LE; Kamphuisen, PW; Lefrandt, JD; Mulder, DJ; Slart, RH; van Roon, AM1
Gomez, MF; Hellberg, S; Huusko, J; Knuuti, J; Liljenbäck, H; Nuutila, P; Roivainen, A; Saraste, A; Silvola, JMU; Söderström, M; Ståhle, M; Virta, J; Ylä-Herttuala, S1
Al-Mallah, MH; Hyafil, F; Santulli, G1

Other Studies

3 other study(ies) available for fluorodeoxyglucose f18 and linagliptin

ArticleYear
Effect of Linagliptin on Arterial
    Journal of the American College of Cardiology, 2017, 02-28, Volume: 69, Issue:8

    Topics: Administration, Oral; Aged; Arteries; Atherosclerosis; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Fluorodeoxyglucose F18; Humans; Linagliptin; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Vascular Stiffness

2017
Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A
    Atherosclerosis, 2020, Volume: 305

    Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fluorodeoxyglucose F18; Inflammation; Linagliptin; Mice; Mice, Knockout; Plaque, Atherosclerotic; Positron-Emission Tomography

2020
No pleotropic effects of linagliptin on atherosclerotic plaques: Case closed.
    Atherosclerosis, 2020, Volume: 305

    Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fluorodeoxyglucose F18; Inflammation; Linagliptin; Mice; Plaque, Atherosclerotic

2020